The company’s Purion process retains the amniotic growth factors and cytokines inherent in placental tissue, which creates an Injectable tissue for reducing inflammation and enhancing soft tissue healing.
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Orthopedic Implants:
Hospital for Special Surgery Research Analyzes Hip Implant Failures
Wright Medical Group Receives FDA Clearance for Patient-Specific Total Ankle Replacement
43 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in January
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.